Evorpacept (ALX148), a CD47-Blocking Myeloid Checkpoint Inhibitor, in Combination with Azacitidine: A Phase 1 / 2 Study in Patients with Myelodysplastic Syndrome (ASPEN-02)Guillermo Garcia-Manero,Harry P. Erba,Srinivasa R. Sanikommu,Jessica K. Altman,Hamid Sayar,Bart L. Scott,Abraham P. Fong,Shanhong Guan,Feng Jin,Alison J. Forgie,Jaume Pons,Sophia S. Randolph,Michael T. ByrneBlood(2021)引用 11|浏览9暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要